Alzheimer's Disease
A progressive neurodegenerative disorder characterized by memory loss, cognitive decline, and behavioral changes. Exploring amyloid-beta plaques, neurofibrillary tangles, and emerging immunotherapies.
Comprehensive, expert-reviewed entries covering etiology, pathophysiology, diagnostic criteria, therapeutic interventions, and current research across neurological, psychiatric, cardiovascular, endocrine, and systemic conditions.
A progressive neurodegenerative disorder characterized by memory loss, cognitive decline, and behavioral changes. Exploring amyloid-beta plaques, neurofibrillary tangles, and emerging immunotherapies.
Persistent feelings of sadness, anhedonia, and functional impairment. Covers DSM-5-TR criteria, neurobiological models, pharmacotherapy, psychotherapy, and treatment-resistant protocols.
Clinical syndrome resulting from structural or functional cardiac abnormalities leading to inadequate cardiac output. Reviews pathophysiology, NYHA classification, and guideline-directed medical therapy.
Autoimmune destruction of pancreatic beta cells leading to absolute insulin deficiency. Covers etiology, clinical presentation, continuous glucose monitoring, and immunomodulatory trials.
Chronic progressive movement disorder caused by dopaminergic neuron loss in the substantia nigra. Details motor/non-motor symptoms, Levodopa therapy, and deep brain stimulation protocols.
Multisystem autoimmune disease characterized by autoantibody production and immune complex deposition. Covers clinical manifestations, ACR/EULAR classification, and biologic therapies.
Severe mental disorders featuring psychosis, disorganized thinking, and negative symptoms. Explores dopamine/glutamate hypotheses, antipsychotic mechanisms, and psychosocial rehabilitation.
Autosomal recessive disorder caused by CFTR gene mutations leading to thick mucus production. Reviews pulmonary complications, CFTR modulators, and multidisciplinary management strategies.
Hereditary neurodegenerative disorder caused by CAG trinucleotide repeat expansion in the HTT gene. Covers chorea, cognitive decline, genetic counseling, and gene-silencing therapies.